Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,025 recruiting studies in this area right now.
By phase
- Not applicable2,810
- Phase 2752
- Phase 1523
- Phase 3382
- Phase 1/Phase 2296
- Phase 4203
- Phase 2/Phase 359
Top conditions
- Breast Cancer1,192
- Melanoma174
- Metastatic Breast Cancer138
- Rheumatoid Arthritis131
- Atopic Dermatitis124
- Systemic Lupus Erythematosus119
- Breast Neoplasms111
- Triple Negative Breast Cancer110
- Colorectal Cancer94
- Ovarian Cancer91
- Psoriasis85
- Breast Carcinoma79
- Lung Cancer77
- Prostate Cancer70
- Rheumatoid Arthritis (RA)68
- Diabetic Foot Ulcer59
- Cancer58
- Systemic Lupus Erythematosus (SLE)52
Leading sponsors
- Fudan University64
- M.D. Anderson Cancer Center51
- Novartis Pharmaceuticals49
- Memorial Sloan Kettering Cancer Center48
- Mayo Clinic40
- AstraZeneca38
- Assistance Publique - Hôpitaux de Paris37
- National Cancer Institute (NCI)37
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34
- Second Affiliated Hospital, Zhejiang University, School of Medicine30
Where studies are running
- California408
- Arizona150
- Alabama129
- Florida126
- New York110
- Texas106
- Maryland94
- Massachusetts87
- Pennsylvania72
- North Carolina68
Recruiting studies5,025 total
- NCT06980961Recruiting
Laser treatment for stasis dermatitis (skin condition)
This study tests two types of laser devices (Omer Smart and Omer Premium) to see if they can help treat stasis dermatitis, a skin condition linked to poor blood flow in the legs. If you have already had treatment for varicose veins and your dermatitis is still bothering you, this trial may be an option.
Santo André, São PauloAges Any age - NCT06915857RecruitingPhase 3
Betamethasone cream vs moisturizer for radiation rash in large-breasted women
This trial tests whether a betamethasone steroid cream works better than regular moisturizer to prevent skin reactions from radiation therapy. It is for women with large breasts who are getting radiation lying face down after breast-conserving surgery.
Toronto, OntarioAges 18 years+ - NCT05999396RecruitingPhase 1
Testing a new antibody for colorectal cancer
This trial tests a new drug called CC-3, which is a type of antibody designed to help your immune system attack colorectal cancer cells. It is for people whose cancer has spread and who have already tried several standard treatments.
Tübingen, Baden-WurttembergAges 18 years+ - NCT06298019RecruitingPhase 1
CAR T-cell therapy for tough dermatomyositis
This study tests a new immune therapy called CAR T-cells (KYV-101) for people with active, tough-to-treat dermatomyositis. It aims to see if the treatment is safe and can reduce muscle weakness and skin rash.
Palo Alto, CaliforniaAges 25–72 - NCT07068074RecruitingPhase 3
Comparing less invasive surgery to standard care for older adults with early-stage melanoma
This trial compares less invasive procedures with the current standard treatment for early-stage melanoma in adults 75 and older. The goal is to find out if these less invasive options work just as well and help patients recover better.
Birmingham, AlabamaAges 75 years+ - NCT07067138Recruiting
Genetic testing to guide treatment for advanced breast cancer
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
Bethesda, MarylandAges 18–120 - NCT07071363Recruiting
Serum vs hydroquinone for melasma treatment
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
Port Louis, PhoenixAges 18–65 - NCT07072728RecruitingPhase 2
Psilocybin therapy for anxiety in cancer patients
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
Abbotsford, VictoriaAges 18–80 - NCT07070128Recruiting
AI screening tool for breast cancer genetic risk
This trial tests an AI tool that predicts genetic risk for breast cancer. It may help women identified as high-risk by their breast surgeon get quicker genetic counseling.
Golania, GoiásAges Any age - NCT07073677RecruitingPhase 2
Testing a new eczema ointment for mild to moderate cases
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
Ansan, ALLAges 19 years+ - NCT07070232RecruitingPhase 1/Phase 2
Testing a new drug BNT326 for advanced cancers
This trial tests a new medicine called BNT326, alone or with another drug BNT327, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and might help shrink tumors.
Phoenix, ArizonaAges 18 years+ - NCT07070518RecruitingPhase 1/Phase 2
Study of GV20-0251 for advanced solid tumors
This trial tests a new study drug, GV20-0251, for people with advanced solid tumors that no longer respond to standard therapies. It aims to see if the drug can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07071337RecruitingPhase 3
Study of SKB264 vs chemo for HR+/HER2- breast cancer after hormone therapy
This trial tests a new drug, SKB264, against standard chemotherapy for people with a common type of breast cancer (HR+/HER2-) that has spread and stopped responding to hormone therapy. It may offer a new option if you haven't had chemotherapy for advanced disease.
Beijing, Beijing MunicipalityAges 18–75 - NCT05333328RecruitingPhase 4
Test of ovarian function suppression for low-risk premenopausal node+ breast cancer
This trial studies whether ovarian function suppression (a treatment that lowers hormone production from the ovaries) helps women with hormone-receptor positive, HER2-negative breast cancer that has spread to lymph nodes, but who have a low-risk result on a genomic test. It may help reduce breast cancer recurrence while avoiding more intensive treatment for those who are lower risk.
Seoul, KoreaAges 20–50 - NCT07065747Recruiting
Understanding inflammation in uveitis using advanced eye imaging
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
Portland, OregonAges 5–85 - NCT07073755Recruiting
Study of next treatments after targeted therapy resistance for advanced breast cancer
This study looks at what happens when people with advanced breast cancer switch to a new treatment after their cancer becomes resistant to targeted therapies like CDK4/6 inhibitors, PIK3CA inhibitors, or T-DXd. Researchers want to understand which next treatments work best in real life.
Changsha, HunanAges 18 years+ - NCT07070765Recruiting
Study on dapagliflozin to protect the heart during breast cancer chemo
This trial tests if a heart-protecting drug called dapagliflozin can help prevent heart damage in breast cancer patients receiving a type of chemotherapy called anthracycline. It may be an option if you have low to medium heart risk factors.
Aberdeen, AberdeenshireAges 18–70 - NCT07066917Recruiting
Breast cancer treatment response study
This study looks at how well newer treatments work for advanced or metastatic breast cancer and why some people respond better than others. It is for anyone with HR-positive, HER2-positive/low, or triple-negative breast cancer who has started at least one treatment cycle.
AthensAges 18 years+ - NCT07067437Recruiting
Single-dose radiation after breast cancer surgery
This trial tests a new, shorter radiation treatment given all at once after breast-conserving surgery for early-stage breast cancer. It is for people with small tumors that have not spread far, and aims to reduce side effects and visits to the clinic.
LyonAges 40 years+ - NCT07073040Recruiting
Cold plasma therapy for diabetic foot ulcers with blocked arteries
This trial tests whether adding cold atmospheric plasma (a gentle gas treatment) to a standard procedure that opens blocked leg arteries can help diabetic foot ulcers heal better and faster.
Anshan, LiaoningAges 18–80 - NCT07067879Recruiting
Lip product with seaweed extract for lip darkening
This study tests a new lip product made with a seaweed extract (Caulerpa lentillifera) to see if it can reduce darkening of the lips. If you have lip hyperpigmentation and want to try a natural option, this may be a good fit.
BangkokAges 18–60 - NCT07070791Recruiting
Exercise program for arm strength and fitness after breast cancer
This trial tests whether a combination of arm-strengthening and aerobic exercises helps breast cancer patients who are at least 15 months past surgery and not very active. The goal is to see if this home-based program improves arm function and overall fitness.
Ankara, StateAges 18–80 - NCT07066189Recruiting
Diet and exercise during chemo for triple negative breast cancer
This study looks at whether a program of healthy eating and exercise, started during chemotherapy, can help shrink your tumor more effectively. You will be randomly assigned to either follow the diet and exercise plan or stick with your usual care.
New Haven, ConnecticutAges 18 years+ - NCT07067788Recruiting
Comparing a new imaging method for breast calcifications
This study tests a new imaging technique to better see suspicious calcifications found during a mammogram. If you have these calcifications, this might help doctors learn more about them.
Philadelphia, PennsylvaniaAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,025 recruiting dermatology studies from the U.S. registry right now, out of 7,809 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.